Últimas noticias sobre Globus Medical (NYSE:GMED) Bolsa

Globus Medical

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Globus Medical, Inc. Class A Common Stock

Globus Medical Inc

It is payable on December 31, 2024, to the shareholders of record at the close of business on December 13, 2024.

News

Dividends

STEL

Stellar Bancorp Boosts Quarterly Cash Dividend From $0.13 To $0.14 Per Share

Denmark is poised to cement its place as a leader in <a href="https://www.benzinga.com/topic/medical-cannabis">medical cannabis</a> regulation. On November 19, Minister of the Interior and Health Sophie Løhde <a href="https://www.ism.dk/nyheder/2024/november/regeringen-vil-goere-ordning-med-medicinsk-cannabis-paa-recept-permanent">proposed</a> making the country's medical cannabis trial scheme permanent, a bold move following <a href="https://www.benzinga.com/markets/cannabis/23/10/35346758/europes-high-irish-gps-against-pot-switzerland-spain-share-data-on-cannabis-clubs-more">years of steady growth</a> in patient participation.
<h4 class="wp-block-heading">Medical Cannabis Success in Denmark</h4>
The trial scheme, introduced in 2018, aimed to provide patients with conditions such as multiple sclerosis and cancer access to medical cannabis treatments. Extended in 2021, the program is set to expire at the end of 2025. However, its success has been undeniable. Over the last three years, more than 20,000 prescriptions have been redeemed, and approximately 1,800 patients are currently benefiting from cannabis-based medicines.
Minister Løhde highlighted the program&#8217;s impact: "We see that many patients who receive medical cannabis prescriptions appear to benefit from the treatment. This includes cancer patients suffering from severe nausea after chemotherapy and people with multiple sclerosis experiencing intense pain."
<h4 class="wp-block-heading">The Road to Permanency</h4>
The government's proposal reflects its commitment to ensuring continued legal access to medical cannabis for patients. Minister Løhde emphasized the need for collaboration, stating, "We first need to hear the perspectives of the parties involved in the agreement."
On November 19, Løhde invited representatives from political groups behind the original agreement—SF, Liberal Alliance, Red-Green Alliance, Danish People&#8217;s Party, and the Alternative—to discuss the scheme's future.
<h4 class="wp-block-heading">Industry Support</h4>
Denmark's cannabis industry also welcomed the news. Thomas Skovlund Schnegelsberg, CEO of Danish MMJ producer Stenocare, expressed optimism about the proposal. "It is excellent news for patients and Stenocare that the government is now taking steps toward permanent legalization. We are confident that the future of medical cannabis treatment is in good hands," adding that "the permanent legalization will establish a clear framework for the future, offering clarity beyond December 2025 and justifying investments in new products that deliver value to both doctors and patients."
As negotiations unfold, Denmark appears ready to solidify its role as a pioneer in regulated medical cannabis, offering hope and legal options to patients across the country.
Cover image made with AI

Cannabis

Psychedelics

Regulations

Eurozone

Denmark Moves Toward Permanent Medical Cannabis Program

Pareto Securities analyst Eirik Haavaldsen downgrades Golden Ocean Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) from Buy to Hold and announces $12.5 price target.

Downgrades

Price Target

Analyst Ratings

GOGL

Pareto Securities Downgrades Golden Ocean Group to Hold, Announces $12.5 Price Target

ZVRA

Zevra Therapeutics Says MIPLYFFA, The First Treatment Approved By FDA For  Treatment Of Nieman Pick Disease Type C, Is Now Commercially Available For Dispense

Connexa Sports Technologies Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) is pleased to announce that it has closed the acquisition of a further 50% ownership stake in Yuanyu Enterprise Management Co., Limited (YYEM), a Hong Kong-based entity focused on the global Love and Marriage sector, taking its overall stake in YYEM to 70% and received Nasdaq confirmation that post-acquisition trading of YYAI will commence at the market opening tomorrow morning on November 22, 2024.
As a result of the acquisition, Connexa has now undergone a change of control, appointed new officers, new directors, and effected a spin-off of the Slinger Bag business.

Connexa Sports Technologies Inc. - Common Stock

YYAI

Connexa Sports Announces It Has Closed The Acquisition Of A Further 50% Ownership Stake In Yuanyu Enterprise Management Co., Taking Its Overall Stake In YYEM To 70% And Received Nasdaq Confirmation That Post-Acquisition Trading Of YYAI Will Commence At The Market Opening Tomorrow Morning On November 22, 2024

NetApp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) reported its second-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b42123040/netapp-reports-second-quarter-of-fiscal-year-2025-results">details from the report. </a>
The Details: NetApp reported quarterly earnings of $1.87 per share, which beat the analyst consensus estimate of $1.78. Quarterly revenue came in at $1.65 billion, which beat the analyst consensus estimate of $1.64 billion and is an increase over revenue of $1.56 billion from the same period last year.
The company reported: 
<ul>
<li>Hybrid Cloud segment revenue of $1.49 billion, compared to $1.41 billion in the second quarter of fiscal year 2024. Public Cloud segment revenue of $168 million, compared to $154 million in the second quarter of fiscal year 2024.</li>
<li>Billings of $1.59 billion, compared to $1.45 billion in the second quarter of fiscal year 2024, a year-over-year increase of 9%.</li>
<li>Record all-flash array annualized net revenue run rate of $3.8 billion, an increase of 19% year-over-year.</li>
<li>First party and marketplace cloud storage services revenue grew approximately 43% year-over-year.</li>
<li>Record second quarter non-GAAP operating margin of 29%. </li>
<li>Returned $406 million to stockholders through share repurchases and cash dividends. </li>
</ul>
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
&#8220;Our strong Q2 performance was driven by another record-breaking quarter in all-flash storage and strong performance in first party and marketplace cloud storage services,&#8221; said George Kurian, CEO of NetApp. 
&#8220;Broad-based customer preference for our intelligent data infrastructure platform and visionary approach for a data-driven future has enabled us to outgrow the market and take share from competitors. Our focus and momentum fuel my confidence in our ability to deliver outstanding results for customers and shareholders,&#8221; Kurian added. 
NTAP Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, NetApp shares are up 4.16% after-hours at $131.95 at the time of publication Thursday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Courtesy of NetApp, Inc.

Earnings

After-Hours Center

Movers

Tech

NTAP

NetApp Stock Climbs After Better-Than-Expected Q2 Results

Cryptocurrency Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) has soared over the past week, but remains well below the all-time highs <a href="https://www.benzinga.com/24/11/42018208/bitcoin-ethereum-dogecoin-pepe-shiba-inu-benzinga-readers-pick-this-crypto-to-have-the-biggest-gain-before-end-of-2025">set back in 2021.</a>
While Ethereum&#8217;s gains in 2024 are less than those of other cryptocurrencies, the second-largest crypto still trades significantly higher than when it launched in 2015.
What Happened: Ethereum co-founder Vitalik Buterin proposed the digital currency via a 2014 white paper, with the goal of adding scripting to make it easier for application development and to <a href="https://www.benzinga.com/markets/cryptocurrency/21/09/22811912/5-things-you-might-not-know-about-ethereum-creator-vitalik-buterin-3" target="_blank" rel="noreferrer noopener">set up binding contracts.</a>
Ethereum was officially launched on July 30, 2015. During its first calendar year, Ethereum traded between $0.42 and $1.39 with a starting price of around $0.74 according to&nbsp;<a href="https://www.sofi.com/learn/content/ethereum-price-history/" target="_blank" rel="noreferrer noopener">SoFi</a>. The first Ethereum transaction was carried out on Aug. 7, 2015,&nbsp;<a href="https://www.globaldata.com/data-insights/financial-services/ethereums-price-history/" target="_blank" rel="noreferrer noopener">according&nbsp;</a>to Global Data.
Ethereum gained momentum thanks to its listing on cryptocurrency platform&nbsp;Coinbase Global Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>). It became the second-ever cryptocurrency, after&nbsp;Bitcoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), to be listed on the platform.
Over the years there have been several major events and updates to Ethereum including the fork of Ethereum 2.0 and&nbsp;Ethereum Classic&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/etc/usd">ETC</a>).
Ethereum saw increased attention and a surge in valuation related to the boom of non-fungible tokens in 2021. Many of the NFTs were built on the Ethereum blockchain, including&nbsp;CryptoPunks&nbsp;and&nbsp;Bored Ape Yacht Club. A record sale of a&nbsp;Beeple&nbsp;NFT&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/21/03/20134939/beeple-nft-sold-for-a-record-69-million" target="_blank" rel="noreferrer noopener">created interest in NFTs&nbsp;</a>and Ethereum.
Today, Ethereum is the second most valuable cryptocurrency with a market capitalization of $403.1 billion.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42095265/4-reasons-why-ethereum-will-still-outperform-bitcoin-analyst-sees-4000-to-6000-as-target">4 Reasons Why Ethereum Will Still Outperform Bitcoin—Analyst Sees $4,000 To $6,000 As Target</a>
Investing $1,000 in Ethereum:&nbsp;An investment in the second largest cryptocurrency the year it launched would have generated a strong return for investors.
While it was harder to invest in Ethereum prior to its inclusion on major cryptocurrency exchanges, investors were able to purchase the crypto after it launched.
Based on a starting price of $0.74, an investor could have purchased 1,351.35 ETH at the time of launch.
The $1,000 investment in Ethereum at launch would be worth $4,512,009.00 today based on a price of $3,338.89 at the time of writing.
At its all-time high of $4,815 set in November 2021, the $1,000 investment in Ethereum at the time of launch would have been worth $6,506,750.25.
Ethereum has traded between $1,988.12 and $4,092.28 over the last 52 weeks. There is no guarantee that the cryptocurrency will return to yearly or all-time highs.
While many missed out on investing in Ethereum in the early days, the exercise shows that sometimes investing a small amount in a high-conviction idea can have a huge payout in the future.
Ethereum is nearing its one-year high and could be headed towards its all-time high set on Nov. 16, 2021.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/21/10/23210010/the-butterfly-effect-heres-the-crazy-story-of-how-world-of-warcraft-led-to-the-creation-2">The Butterfly Effect: Here&#8217;s The Crazy Story Of How World Of Warcraft Led To The Creation Of Ethereum</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$BTC

$ETC

$ETH

COIN

If You Invested $1,000 In Ethereum At Launch, Here's How Much You'd Have Today

The Company intends to use the net proceeds of this offering to fund the SERENITY At-Home trial, prepare for the initiation of the TRANQUILITY In-Care trial, working capital and general corporate purposes.
 &nbsp;

Offerings

BTAI

BioXcel Therapeutics Commences Public Offering Of Shares Of Its Common Stock And Accompanying Warrants; No Terms Disclosed

WIIM

KSCP

Knightscope shares are trading lower after the company announced a proposed public offering of Class A common stock and pre-funded warrants to address working capital needs.

GEOS

Geospace Technologies Q4 EPS $(1.00) Down From $0.33 YoY, Sales $35.4M Up From $29.3M YoY

Gap, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the key figures from the quarter.
The Details:&nbsp;Gap reported quarterly earnings of 72 cents per share, which beat the analyst consensus estimate of 57 cents. Quarterly revenue came in at $3.82 billion, which beat the consensus estimate of $3.81 billion and is an increase over sales of $3.76 billion from the same period last year.
<ul>
<li>Net sales increased 2% versus last year with comparable sales up 1%.</li>
<li>Operating margin of 9.3% improved 270 basis points versus last year.</li>
<li>Market share gains across all brands in the quarter.</li>
<li>Gross margin of 42.7% increased 140 basis points versus last year&#8217;s gross margin.</li>
<li>Merchandise margin increased 90 basis points versus last year primarily driven by improved inventory management.</li>
<li>Ending inventory of $2.33 billion was down 2% compared to last year.</li>
<li>Athleta net sales of $290 million were up 4% compared to last year.</li>
<li>Old Navy net sales of $2.2 billion were up 1% compared to last year.</li>
<li>Gap net sales of $899 million were up 1% compared to last year.</li>
<li>Banana Republic net sales of $469 million were up 2% compared to last year.</li>
</ul>
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
&#8220;I&#8217;m proud that Gap Inc. delivered another successful quarter, growing net sales for the fourth consecutive quarter and gaining market share across all brands while meaningfully expanding operating margin,&#8221; said Gap CEO Richard Dickson.
&#8220;Consistent execution of our strategic priorities, including the rigor and repetition we&#8217;re applying to our brand reinvigoration playbook, is making us a stronger company and demonstrates our continued progress in unlocking Gap Inc.&#8217;s full potential,&#8221; Dickson added. 
Outlook:&nbsp;Gap raised its full-year outlook for net sales, gross margin and operating income growth compared to prior expectations. The company now sees net sales up 1.5% to 2%, gross margin growth of 220 basis points and operating income margin of mid-to-high 60%.
GAP Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Gap shares are up 12.98% after-hours at $24.90 after gaining 6.89% during Thursday&#8217;s regular trading session.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Image: Courtesy of Gap, Inc.&nbsp;

Gap Stock Soars On Better-Than-Expected Q3 Results, Raised FY Guidance: Details

American States Water Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWR#NYSE">AWR</a>) announced that on November 15, 2024, its regulated water utility subsidiary, Golden State Water Company ("GSWC"), received a proposed decision from the assigned administrative law judge at the California Public Utilities Commission ("CPUC") in connection with the pending general rate case proceeding that will determine new water rates for the years 2025 – 2027. A final decision by the CPUC is expected as soon as the end of the fourth quarter of 2024. When a final decision is issued by the CPUC, the new rates for 2025 will be effective January 1, 2025.
On July 12, 2024, GSWC and the Public Advocates Office ("Cal Advocates") at the CPUC filed a joint motion to adopt a settlement agreement between GSWC and Cal Advocates in the general rate case proceeding. The proposed decision approves and adopts the settlement agreement in its entirety. Among other things, the settlement agreement authorizes GSWC to invest approximately $573.1 million in capital infrastructure over the three-year cycle in order to continue to provide safe and reliable water utility service to its customers, which includes $17.7 million of advice letter capital investments to be filed for revenue recovery during the second and third year attrition increases when those projects are completed. In addition, the settlement agreement approves $58.2 million of advice letter capital investments already under construction beginning in 2023 also to be filed for revenue recovery during the second and third year attrition increases when those projects are completed. The settlement agreement also allows for additional increases in adopted revenues for 2026 and 2027 subject to an earnings test and changes to the forecasted inflationary index values. Actual increases for 2026 and 2027 will be determined at the time the filings to implement the new rate increases are approved by the CPUC, and will be calculated using inflationary index values at that time.
Furthermore, the proposed decision addressed the two remaining unresolved 2025 revenue requirement issues related to GSWC's sales forecast and supply mix. The proposed decision adopts GSWC's recommended sales forecast and adopts a supply mix that splits the difference between GSWC's and Cal Advocates' forecasts. The proposed decision also addressed the unresolved issues related to GSWC's requests for certain regulatory mechanisms. With regards to these requests, the proposed decision (i) rejects GSWC's request for continuation of a full sales and revenue decoupling mechanism and a full cost balancing account for water supply, and instead orders GSWC to transition to a modified rate adjustment mechanism (a Monterey-style WRAM or "M-WRAM") and an incremental cost balancing account for supply costs, (ii) rejects GSWC's sales reconciliation and supply mix adjustment mechanisms, and (iii) rejects GSWC's request to modify the existing per- and polyfluoroalkyl substances ("PFAS") memorandum account to track carrying costs on capital investments needed to comply with the new PFAS maximum contaminant levels established by the Environmental Protection Agency, and instead orders GSWC to file for recovery of PFAS-related capital projects through a separate application or future general rate case. The proposed decision adopts GSWC's M-WRAM rate design proposal, authorizing GSWC to increase the revenue requirement in its service charges to between 45-48% depending on the ratemaking area representing approximately 65% of GSWC's fixed costs in aggregate. GSWC will file comments on the proposed decision by December 5, 2024. The proposed decision is scheduled to be voted on by the CPUC on December 19, 2024.

Contracts

Legal

American States Water Company Announces Proposed Decision Adopting Settlement Agreement In Its Water Utility General Rate Case; Settlement Agreement Authorizes GSWC To Invest ~$573.1M In Capital Infrastructure Over The 3-Year Cycle In Order To Continue To Provide Safe And Reliable Water Utility Service To Its Customers

Cheche Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCG#NASDAQ">CCG</a>) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that it received a notification letter dated November 15, 2024 (the "Notification Letter "), from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq"), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules as the Company's closing bid price per Class A ordinary share, par value US$0.00001 per share, has been below US$1.00 for a period of 30 consecutive business days. The Notification Letter does not result in the immediate delisting of the Company's securities.
The Company would like to clarify that the Notification Letter has no current effect on the listing or trading of the Company's securities on Nasdaq. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 14, 2025&nbsp;(the "Compliance Period"), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per Class A ordinary share&nbsp;is at least US$1.00 for&nbsp;a minimum&nbsp;of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed.

Cheche Group Announces Receipt Of Notification Letter From Nasdaq Regarding Minimum Price Deficiency

5E Advanced Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>) reported quarterly losses of $(0.20) per share. This is a 4.76 percent increase over losses of $(0.21) per share from the same period last year.

FEAM

5E Advanced Materials Q1 EPS $(0.20) Up From $(0.21) YoY

Each of these projects is expected to start in 2025 and will be completed within 20 months.
Orion Marine was awarded a significant $88 million contract by South Carolina State Ports Authority in a competitive bid process.&nbsp;
In addition, Orion Marine was awarded a $12.9 million subcontract to Haskell.
&nbsp;
&nbsp;

Orion Group Secures Three Contract Awards, Two In Its Marine Segment And One In Its Concrete Segment Valued At Approximately $111M

FLUX

Flux Power shares are trading lower. The company announced the retirement of its CEO who also serves as chairman.

Management

Oceaneering Announces Promotion Of Benjamin M. Laura To Senior Vice President And Chief Operating Officer

MDU Resources plans to increase investments in its electric and natural gas distribution segments by 47% over the next five years compared to 2020-2024.&nbsp;
&nbsp;

Guidance

MDU Resources Plans To Make Capital Investments Totaling $3.1B From 2025 Through 2029, Up 15% From 2024-2028; Remains Committed To Long-Term EPS Growth Target Of 6%-8% With Enhanced Capital Investment Plan

THRM

Gentherm Appoints Jonathan Douyard As Executive Vice President, CFO And Treasurer

MDU Resources Sees 2025 Capital Investments Of $3.1B From 2025-2029, Up 15% From 2024-2028

Wells Fargo analyst Vik Chopra has assigned their bullish stance on GMED stock, giving a Buy rating yesterday. Vik Chopra has given his Buy rating ...

Globus Medical's Strong Q3 Performance and Optimistic Outlook Justify Buy Rating

Truist Financial analyst Richard Newitter maintained a Hold rating on Globus Medical (GMED – Research Report) today and set a price target of $85.0...

Truist Financial Sticks to Its Hold Rating for Globus Medical (GMED)

Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)

Piper Sandler analyst Matt O'Brien raised the firm's price target on Globus Medical (GMED) to $100 from $80 and keeps an Overweight rating on the s...

Globus Medical price target raised to $100 from $80 at Piper Sandler

Stifel analyst Mathew Blackman raised the firm's price target on Globus Medical (GMED) to $92 from $80 and keeps a Buy rating on the shares. Q3 "se...

Globus Medical price target raised to $92 from $80 at Stifel

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS – CVS Health (CVS) up 12% Vertex (VERX) up 6% I...

Morning Movers: CVS Health surges and ODP sinks following Q3 results

RBC Capital raised the firm's price target on Globus Medical (GMED) to $92 from $80 and keeps an Outperform rating on the shares. The company issue...

Globus Medical price target raised to $92 from $80 at RBC Capital

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has give...

Comments

Globus Medical

Noticias

Últimas noticias sobre Globus Medical (NYSE:GMED) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL